dri
flower
daphn
genkwa
sieb
et
zucc
thymelaeacea
chines
herbal
medicin
use
abortifaci
purg
diuret
antiinflammatori
activ
howev
activ
medicin
enterovir
infect
investig
waterextract
dri
bud
genkwa
sieb
et
zucc
dgfw
examin
variou
strain
enteroviru
neutral
assay
initi
mode
action
character
timeofaddit
assay
follow
attach
penetr
assay
pretreat
dgfw
viru
abolish
viral
replic
indic
dgfw
inhibit
target
viru
gfw
exert
effect
inhibit
viral
entri
without
produc
cytotox
side
effect
thu
provid
potenti
agent
antivir
chemotherapeut
enteroviru
positivestrand
rna
viru
belong
enteroviru
genu
famili
picornavirida
member
picornavirida
famili
rna
genom
kb
length
encod
amino
acid
polyprotein
cleav
proteolyt
distinct
protein
viralencod
proteas
pro
pro
structur
protein
compris
nonstructur
protein
requir
viral
replic
common
enteroviru
usual
caus
hand
foot
mouth
diseas
children
often
associ
brainstem
enceph
neurogen
shock
poliolik
acut
flaccid
paralysi
caus
outbreak
mortal
manifest
neurolog
involv
cardiopulmonari
failur
longterm
studi
survivor
cn
infect
found
neurolog
sequela
retard
mental
develop
sever
epidem
occur
caus
total
fatal
unfortun
therapi
proven
efficaci
control
given
recur
outbreak
annual
epidem
clear
need
develop
inhibitor
virus
must
deliv
genom
host
cell
initi
replic
enter
cell
endocytosi
hijack
cellular
machineri
attach
receptor
subsequ
penetr
across
plasma
membran
sever
receptor
facilit
entri
report
includ
scaveng
receptor
human
pselectin
glycoprotein
sialyl
glycan
strategi
disrupt
interact
viral
particl
receptor
would
ideal
antivir
develop
identifi
tradit
chines
medicin
antivir
prophylact
activ
infect
flower
bud
daphn
genkwa
sieb
et
zucc
thymelaeacea
known
wonhwa
yuanhua
chines
collect
spring
blossom
tradit
medicin
use
abortifaci
purg
diuret
antiinflammatori
action
previou
phytochem
studi
genkwa
led
isol
pharmacolog
activ
flavonoid
diterpen
orthoest
coumarin
show
inhibitori
activ
xanthin
oxidas
adenosin
monophosph
phosphodiesteras
well
exhibit
antileukem
activ
present
studi
use
chines
tradit
medicin
extract
activ
found
daphn
genkwa
sieb
et
zucc
extract
dgfw
could
neutral
cytopath
effect
cpe
human
embryon
rhabdomyosarcoma
rd
cell
half
maxim
effect
concentr
ec
dgfw
approxim
mgml
dgfw
inhibit
viral
protein
viral
rna
synthesi
addit
dgfw
suppress
viral
activ
adsorpt
stage
uptak
shown
timeofaddit
assay
cell
pretreat
dgfw
could
block
viral
infect
therefor
possibl
dgfw
bind
viru
affect
activ
conclud
dgfw
possess
antivir
activ
potenti
develop
agent
endeavor
identifi
chines
medicin
initi
screen
panel
extract
chines
herb
antioxid
properti
assay
measur
inhibit
virusinduc
cell
death
rd
cell
first
employ
use
mgml
herbal
extract
follow
ec
determin
candid
possess
antivir
activ
primari
screen
identifi
water
fraction
genkwa
potent
agent
isol
ec
mgml
concentr
produc
cytotox
cc
mgml
use
rd
cell
tabl
howev
solvent
chcl
layer
demonstr
activ
figur
dgfw
also
abl
inhibit
success
isol
except
isol
genotyp
tabl
interestingli
extract
effect
influenza
viru
although
select
index
satisfactori
howev
dgfw
show
activ
cv
two
dna
virus
adenoviru
concentr
mgml
tabl
prepar
dgfw
shown
figur
final
dri
extract
weigh
dissolv
dmso
antivir
analysi
explor
effect
dgfw
protect
virusinduc
cpe
rd
cell
microscop
assay
figur
rd
cell
infect
isol
presenc
absenc
mgml
toxic
cell
mtt
assay
figur
rd
cell
infect
viru
display
typic
cpe
cell
becam
round
eventu
detach
cultur
dish
panel
figur
effect
caus
dgfw
alon
panel
b
figur
vehicl
dmso
panel
c
figur
dgfw
dmso
protect
cell
virusinduc
cpe
panel
e
versu
f
figur
indic
dgfw
inhibit
viral
replic
therefor
perform
qpcr
western
blot
confirm
antivir
effect
dgfw
figur
cell
first
infect
viru
presenc
absenc
dgfw
cell
harvest
indic
point
figur
amount
viral
rna
quantifi
standard
curv
known
concentr
synthesi
viral
protein
measur
viral
protein
dgfw
substanti
reduc
synthesi
viral
rna
viral
protein
figur
c
assess
antivir
mode
action
use
timeofaddit
assay
dgfw
ad
differ
stage
one
infect
cycl
figur
dgfw
either
ad
viral
preadsorpt
adsorpt
h
pi
viral
adsorpt
virus
cell
cultur
medium
collect
plaqu
assay
h
pi
figur
dgfw
abl
reduc
viral
titer
consider
viral
preadsorpt
step
h
pi
lane
figur
dgfw
target
cell
ad
viral
preadsorpt
lane
figur
late
stage
viral
packag
releas
inhibit
dgfw
reduct
viral
titer
seen
extract
ad
immedi
viral
adsorpt
lane
figur
altogeth
result
demonstr
dgfw
might
target
cellular
uptak
viru
dgfw
mgml
ad
design
time
b
viral
adsorpt
h
pi
ice
dgfw
mgml
ad
cell
indic
time
treatment
dgfw
wash
replac
fresh
rd
cell
pretreat
dgfw
h
pi
cell
wash
inocul
h
unbound
viru
remov
replac
incub
addit
h
supernat
collect
viral
yield
determin
plaqu
assay
viru
virusonli
control
without
dgfw
treatment
ratio
viral
titer
present
mean
sem
result
two
experi
normal
virusonli
control
set
one
repres
result
two
independ
experi
test
mechan
inhibit
viral
entri
host
cell
dgfw
perform
attach
penetr
assay
viral
uptak
cell
occur
first
bind
receptor
follow
clathrindepend
endocytosi
earli
endosom
attach
assay
use
examin
bind
viru
receptor
penetr
assay
use
test
entri
step
follow
receptor
bind
use
cell
assay
rd
cell
easili
detach
dish
incub
ice
cell
suscept
infect
attach
assay
cell
incub
tcid
h
presenc
dgfw
ice
cytoprotect
dgfw
determin
dgfw
abl
inhibit
attach
cell
ec
mgml
figur
penetr
assay
dgfw
ad
viral
entri
cell
follow
viral
preadsorpt
dgfw
also
abl
inhibit
penetr
ic
mgml
figur
dgfw
might
bind
thu
inhibit
viru
dgfw
display
similar
ic
base
attach
penetr
assay
next
examin
whether
dgfw
act
cell
surfac
via
receptorviru
bind
pretreat
rd
cell
dgfw
min
lane
figur
unbound
dgfw
remov
cell
infect
h
progeni
virus
cell
cultur
medium
harvest
plaqu
assay
h
pi
similarli
pretreat
dgfw
dmso
min
infect
treat
viru
determin
plaqu
assay
figur
pretreat
cell
dgfw
show
reduct
viral
titer
suggest
dgfw
affect
viral
bind
cell
directli
contrast
pretreat
viru
dgfw
caus
substanti
reduct
viral
titer
seen
treatment
dmso
alon
impli
dgfw
might
target
viru
directli
specif
figur
lane
versu
lane
result
consist
timeofaddit
assay
figur
direct
target
effect
demonstr
lower
concentr
dgfw
done
pretreat
viru
dgfw
min
follow
dilut
mixtur
fold
wherebi
dgfw
inhibitori
activ
infect
treat
viru
determin
plaqu
assay
figur
pretreat
dgfw
produc
signific
reduct
viral
titer
compar
dmso
control
suggest
dgfw
suppress
viral
activ
target
viru
directli
figur
h
pi
similarli
rd
cell
pretreat
dgfw
min
viral
adsorpt
h
h
pi
h
pi
cell
cultur
medium
pool
determin
viral
titer
plaqu
assay
indic
presenc
dgfw
h
pi
viru
nontreat
viru
control
titer
set
fold
chang
viral
titer
present
mean
sem
result
two
independ
experi
p
b
preincub
dgfw
mgml
dmso
min
mixtur
dilut
fold
plaqu
assay
viral
titer
pretreat
dmso
set
fold
chang
viral
titer
present
mean
sem
result
two
independ
experi
p
studi
demonstr
dgfw
suppress
viral
adsorpt
rd
cell
timeofaddit
assay
cell
pretreat
dgfw
show
inhibit
viral
infect
indic
dgfw
inhibit
cellular
viral
receptor
howev
dgfw
abl
inhibit
viral
endocytosi
reduc
viral
attach
penetr
host
cell
furthermor
pretreat
viru
dgfw
abolish
viral
replic
indic
dgfw
inhibit
target
viru
directli
figur
current
effect
vaccin
antivir
agent
combat
mani
antienterovir
agent
polioviru
rhinoviru
thu
test
efficaci
pleconaril
win
compound
clinic
develop
report
inhibit
sever
type
enterovirusinduc
mening
asept
mening
win
seri
compound
inhibit
viral
replic
primarili
bind
hydrophob
canyon
region
capsid
protein
stabil
viral
capsid
structur
viru
enter
host
cell
undergo
uncoat
process
howev
pleconaril
effect
inhibit
cpe
induc
cell
cultur
strain
isol
patient
contract
hand
foot
mouth
diseas
demonstr
dgfw
might
target
viral
particl
inhibit
howev
dgfw
show
strong
bind
activ
viru
filter
assay
suggest
dgfw
act
transient
bind
lead
potent
inhibitori
activ
figur
phylogenet
analysi
complet
sequenc
identifi
three
genotyp
b
c
genotyp
b
c
divid
subgenotyp
dgfw
inhibit
belong
subgenotyp
respect
howev
ec
dgfw
subgenotyp
greater
mgml
dose
equival
effect
cytotox
concentr
therefor
consid
inhibitori
effect
demonstr
dgfw
target
viru
inhibit
attach
entri
step
howev
dgfw
inhibit
subgenotyp
explain
demonstr
differ
sequenc
phylogenet
analysi
show
distinct
differ
cvb
consequ
dgfw
inhibit
expect
tabl
addit
dgfw
appear
inhibit
differ
genotyp
differ
degre
might
explain
dgfw
target
cellular
factor
flavonoid
common
constitu
plant
use
tradit
chines
medicin
treat
varieti
diseas
genkwa
use
isol
flavonoid
studi
report
isol
luteolin
tilirosid
apigenin
genkwanin
sitosterol
benzoic
acid
genkwadaphnin
dri
flower
bud
apigenin
show
strong
inhibitori
activ
xanthin
oxidas
well
sever
acut
respiratori
syndrom
coronaviru
sarscov
influenza
viru
luteolin
glycosid
wide
use
antimicrobi
properti
hbv
sarscov
influenza
viru
inhibit
shown
vitro
studi
howev
activ
flavonoid
isol
genkwa
demonstr
interestingli
similar
find
apigenin
abl
inhibit
influenza
viru
show
antivir
activ
hsv
tabl
examin
activ
apigenin
purifi
compound
genkwa
ongo
cautionari
note
daphn
bud
extract
whether
ether
layer
water
layer
also
induc
earli
antigen
express
epsteinbarr
viru
ebv
world
human
popul
latent
ebv
infect
high
associ
nasopharyng
carcinoma
southeast
asia
certain
countri
addit
genkwa
possess
harm
side
effect
abortifaci
activ
thu
need
isol
effect
ingredi
lead
induct
ebv
earli
antigen
product
act
abortifaci
tabl
influenza
viru
obtain
american
type
cell
cultur
amplifi
accordingli
overnight
cultur
monolay
rd
cell
wash
dulbecco
phosphatebuff
salin
dpb
inocul
cvb
multipl
infect
moi
cell
cultur
supernat
contain
viral
progeni
collect
cell
develop
cpe
progeni
virus
insid
cell
releas
three
cycl
freezingthaw
result
viral
suspens
pool
cultur
medium
aliquot
store
use
dri
flower
bud
daphn
genkwa
suppli
authent
depart
pharmaci
chang
gung
memori
hospit
chiayi
taiwan
voucher
specimen
deposit
herbarium
chang
gung
univers
taoyuan
taiwan
dri
flower
bud
kg
extract
methanol
seven
time
l
reflux
h
concentr
give
brown
syrup
g
figur
syrup
suspend
h
partit
chcl
nbutanol
success
watersolubl
layer
concentr
gain
redbrown
syrup
g
monolay
rd
cell
per
well
cultur
plate
overnight
use
use
hereaft
mention
otherwis
viru
suspens
threefold
serial
dilut
dmem
contain
fb
ad
cell
incub
h
subsequ
fix
paraformaldehyd
pfa
h
attach
cell
stain
crystal
violet
room
temperatur
densiti
stain
measur
micropl
reader
dynex
technolog
chantilli
va
usa
dilut
caus
cytopatholog
half
cultur
median
tissu
cultur
infect
dose
calcul
use
reedmuench
method
determin
attach
penetr
assay
perform
similarli
except
preadsorpt
carri
h
ice
neutral
assay
ec
use
test
antivir
efficaci
extract
compound
measur
inhibit
cpe
induc
enteroviru
rd
cell
rd
cell
cellswel
seed
plate
incub
h
co
air
incub
infect
cell
overlaid
differ
concentr
extract
incub
co
air
incub
h
end
incub
cell
fix
pfa
follow
crystal
violet
stain
concentr
requir
extract
reduc
virusinduc
cpe
rel
viru
control
defin
ec
aliquot
rd
cell
per
well
seed
overnight
plate
use
twofold
serial
dilut
dgfw
ad
incub
h
medium
care
withdrawn
without
touch
cell
mtt
bromid
mgml
sigmaaldrich
st
loui
mo
usa
ad
incub
h
dimethylsulfoxid
dmso
ad
dissolv
crystal
absorb
nm
well
measur
use
microtit
plate
reader
mrx
elisa
reader
dynex
technolog
concentr
dgfw
caus
death
cell
defin
cytotox
concentr
cc
monolay
rd
cell
per
well
seed
plate
h
cultur
cell
inocul
serial
dilut
viral
suspens
h
cell
wash
dpb
overlaid
warm
agaros
incub
day
cell
fix
pfa
h
agaros
care
remov
subsequ
stain
crystal
violet
titer
viru
express
plaqueform
unit
pfu
per
ml
electrophoresi
protein
electrotransf
onto
polyvinyliden
fluorid
membran
millipor
billerica
usa
protein
interest
incub
primari
antibodi
h
incub
appropri
secondari
antibodi
protein
detect
use
enhanc
chemiluminesc
western
blot
detect
system
millipor
polyclon
antibodi
monoclon
antibodi
describ
rd
cell
cellsml
seed
plate
challeng
virus
moi
cell
pretreat
virus
h
ice
wash
dpb
ad
h
incub
cell
stain
sulforhodamin
b
srb
acet
acid
cpe
observ
use
microscop
dgfw
treatment
cell
pretreat
mgml
extract
viru
simultan
h
wash
dpb
contain
mgml
dgfw
ad
protect
effect
exert
dgfw
also
observ
incub
h
vitro
transcript
infecti
clone
plasmid
kindli
provid
dr
meishan
ho
academia
sinica
taiwan
serial
dilut
tenfold
spectrophotometr
analysi
determin
rna
concentr
copi
number
standard
rna
molecul
calcul
use
follow
formula
x
rna
transcript
length
nucleotid
viral
rna
mix
nm
forward
revers
primer
sybr
green
pcr
master
mix
appli
biosystem
foster
citi
ca
usa
follow
qpcr
analysi
use
abi
stepon
plu
sequenc
detector
system
appli
biosystem
primer
use
forward
atg
gct
tcg
aat
tgc
revers
ttt
atg
tac
ggc
act
att
att
gapdh
forward
ggt
ctc
ctc
tga
ctt
caa
revers
tca
aag
gtg
gag
gag
standard
curv
plot
ct
valuecross
point
log
amount
standard
ad
thu
gener
use
differ
dilut
standard
rd
cell
cellswel
seed
plate
overnight
cell
preadsorb
moi
h
presenc
mgml
dgfw
cultur
medium
replac
contain
concentr
dgfw
cell
incub
harvest
h
post
infect
pi
total
rna
extract
use
trizol
cdna
prepar
revers
transcript
mmlv
rt
kit
invitrogen
carlsbad
ca
usa
qpcr
analysi
use
specif
viral
primer
forward
atg
gct
tcg
aat
tgc
revers
ttt
atg
tac
ggc
act
att
att
amplif
achiev
use
follow
univers
thermal
cycl
protocol
one
cycl
min
cycl
min
absolut
amount
viral
rna
determin
use
extern
standard
curv
tissu
cultur
plate
seed
rd
cell
cellswel
incub
h
co
air
cell
infect
moi
ice
viral
adsorpt
cell
wash
hank
buffer
salt
solut
remov
unbound
viru
dgfw
mgml
ad
h
h
h
preadsorpt
h
adsorpt
h
h
h
postadsorpt
supernat
harvest
h
pi
viral
titer
determin
plaqueform
assay
tissu
cultur
plate
seed
cell
cellswel
incub
overnight
co
air
cell
chill
ice
h
medium
remov
cell
infect
tcid
presenc
increas
concentr
dgfw
ice
h
medium
contain
unadsorb
viru
remov
cell
wash
three
time
dpb
incub
h
cell
fix
pfa
stain
crystal
violet
cell
viabil
determin
measur
cell
densiti
micropl
reader
mrx
elisa
reader
dynex
technolog
pueraria
lobata
extract
mgml
serv
posit
control
attach
method
describ
tissu
cultur
plate
seed
cell
cellswel
incub
overnight
co
cell
chill
ice
h
medium
remov
cell
infect
tcid
ice
h
medium
contain
unbound
viru
remov
variou
concentr
dgfw
ad
cell
incub
h
trigger
endocytosi
viru
infect
cell
treat
alkalin
phosphatebuff
salin
pb
ph
min
inactiv
virus
penetr
cell
acid
pb
ph
immedi
ad
neutral
mix
neutral
medium
remov
replac
cell
incub
h
cell
fix
pfa
subject
crystal
violet
stain
pueraria
lobata
extract
mgml
serv
posit
control
penetr
assay
modifi
previou
report
data
express
mean
standard
error
mean
analyz
use
twotail
student
ttest
p
taken
signific
gfw
exert
effect
inhibit
viral
entri
without
produc
cytotox
side
effect
thu
provid
potenti
agent
antivir
chemotherapeut
